Aftovaxpur DOE (60) O1 BFS + SAT2 Saudi Arabia
  • Foot-and-mouth disease virus, serotype O, strain …
  • Foot-and-mouth disease virus, serotype SAT2, stra…
  • Valid
Authorised in these countries:
  • Denmark
  • Ireland
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Germany
  • Estonia
  • Spain
  • Finland
  • France
  • Greece
  • Croatia
  • Hungary
  • Iceland
  • Italy
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Latvia
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Sweden
  • Slovenia
  • Slovakia
  • United Kingdom (Northern Ireland)
Export to PDF

Product identification

Medicine name:
Aftovaxpur DOE (60) O1 BFS + SAT2 Saudi Arabia
Active substance and strength:
  • Foot-and-mouth disease virus, serotype O, strain …
  • Foot-and-mouth disease virus, serotype SAT2, stra…
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA04
Authorisation number:
This information is not available for this product.
Product identification number:
  • C8038B1A-B025-A912-E053-6B2A10AC5553
Permanent identification number:
  • 600000000084

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
  • Subcutaneous use
    • Cattle
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day

Availability

Package description:
  • Packaging:Bottle (polypropylene), Package_size:1 bottle, Content:300 ml
  • Packaging:Bottle (polypropylene), Package_size:1 bottle, Content:20 ml
  • Packaging:Bottle (polypropylene), Package_size:10 bottles, Content:100 ml
  • Packaging:Bottle (polypropylene), Package_size:10 bottles, Content:50 ml
  • Packaging:Bottle (polypropylene), Package_size:10 bottles, Content:300 ml
  • Packaging:Bottle (polypropylene), Package_size:10 bottles, Content:20 ml
  • Packaging:Bottle (polypropylene), Package_size:1 bottle, Content:200 ml
  • Packaging:Bottle (polypropylene), Package_size:1 bottle, Content:100 ml
  • Packaging:Bottle (polypropylene), Package_size:1 bottle, Content:50 ml
  • Packaging:Bottle (polypropylene), Package_size:10 bottles, Content:200 ml
Manufacturing sites for batch release:
This information is not available for this product.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • EMEA/V/C/002292
Date of authorisation status change:
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
This information is not available for this product.
Responsible authority:
  • European Commission
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
ema-puar-aftovaxpur-v-2292-par-en.pdf (PDF)
First published:
Last updated:
ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf (PDF)
First published:
Last updated:
ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
Combined File of all Documents (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."